Skip to main content

MAXCYTE, INC.

For the period ended Dec 31, 2025. Filed Mar 25, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 25, 2026

MXCT$1.30+3.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
​​​​​​​
Assets · ​ · ​ · ​ · ​ · ​
Current assets: · ​ · ​ · ​ · ​
Cash and cash equivalents​$20,065​$27,884
Short-term investments, at amortized cost​82,979​126,598
Accounts receivable, net​3,503​4,682
Inventory​7,547​8,914
Prepaid expenses and other current assets​4,275​3,606
Total current assets​118,369​171,684
​​​​​​​
Investments, non-current, at amortized cost​​52,570​​35,781
Property and equipment, net​​17,531​19,707
Right-of-use asset - operating leases​​10,920​10,766
Intangible assets, net​​650​​—
Other assets​2,467​1,532
Total assets​$202,507​$239,470
​​​​​​​
Liabilities and stockholders’ equity​​​​
Current liabilities:​​​​
Accounts payable​$1,401​$1,358
Accrued expenses and other​7,812​8,302
Operating lease liability, current​1,456​864
Deferred revenue, current portion​3,598​5,251
Total current liabilities​14,267​15,775
​​​​​​​
Operating lease liability, net of current portion​16,487​17,170
Other liabilities​263​274
Total liabilities​31,017​33,219
​​​​​​​
Commitments and contingencies (Note 8)​​​​
Stockholders’ equity​​​​
Preferred stock, $0.01 par value; 5,000,000 shares authorized and no shares issued and outstanding at December 31, 2025 and December 31, 2024​​—​​—
Common stock, $0.01 par value; 400,000,000 shares authorized, 106,789,618 and 105,711,093 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively​​1,068​​1,057
Additional paid-in capital​431,905​422,047
Accumulated deficit​(261,483)​(216,853)
Total stockholders’ equity​171,490​206,251
Total liabilities and stockholders’ equity​$202,507​$239,470
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.